The ligand-activated transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) has been reported as a candidate for a therapeutic target in malignant tumors, including chondrosarcomas [76,77]. This evidence concerns the gene PPARG and chondrosarcoma.